Zhong‐Ke Yao

Memorial Sloan Kettering Cancer Center

Papers

1

Total Citations

4

H-Index

1

About

Dr. Zhong-Ke Yao is pioneering the integration of fluorescence-guided surgery with advanced molecular imaging, with a primary focus on intraoperative nerve identification. Their most notable contribution is the development and clinical characterization of Rizedisben, a myelin-binding fluorophore that fluoresces in the blue light spectrum (370–425 nm) to enhance real-time visualization of nerves during minimally invasive procedures. This work addresses a critical challenge in surgery—avoiding nerve damage—by providing surgeons with a reliable optical contrast agent. In their landmark 2025 study, Dr. Yao systematically determined the optimal safe and effective dosing parameters for Rizedisben, laying the groundwork for its translational application. With 4 citations already accrued, this foundational paper is poised to influence a growing field. Dr. Yao’s research sits at the intersection of biomedical optics, surgical oncology, and neuroprotection, offering a tangible path toward safer, more precise operations. Their work is especially relevant for students and researchers interested in theranostics, image-guided interventions, and the clinical translation of novel fluorophores.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Rizedisben in Minimally Invasive Surgery
4 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 27
🏛 Institutions: Memorial Sloan Kettering Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago